Citation Impact
Citing Papers
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
2006 Standout
Depression rating scales in Parkinson's disease: Critique and recommendations
2007
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder
2002
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
2006 Standout
Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration
2013
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Automatic classification of MR scans in Alzheimer's disease
2008 Standout
Parkinson disease
2017 Standout
A review of quality of life instruments used in dementia
2005
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
2011 Standout
α-Synuclein and the Lewy body disorders
2001
Vascular dementia
2015 Standout
Oxidative Stress Hypothesis in Alzheimer's Disease
1997 Standout
Transplantation in Parkinson’s Disease
2007
Systematic Review of the Diagnostic Accuracy of 99mTc-HMPAO-SPECT in Dementia
2004
Lewy body cortical involvement may not always predict dementia in Parkinson's disease
2003
Dopamine Transporter Loss Visualized With FP-CIT SPECT in the Differential Diagnosis of Dementia With Lewy Bodies
2004
Alzheimer's disease
2011 Standout
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Parkinson's disease: clinical features and diagnosis
2008 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
Staging of brain pathology related to sporadic Parkinson’s disease
2002 Standout
Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation
2001
Neuroimaging in Alzheimer disease: an evidence-based review
2003
The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screening
2006 Standout
Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium
2005
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
2007 Standout
Epidemiology of Parkinson's disease
2006 Standout
Overdependence on degraded gist memory in Alzheimer's disease.
2006 Standout
Click chemistry based rapid one-pot synthesis and evaluation for protease inhibition of new tetracyclic triazole fused benzodiazepine derivatives
2009
Role of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
2003 StandoutNobel
Nonmedical Influences on the Use of Cholinesterase Inhibitors in Dementia Care
2007
Dementia of the Alzheimer Type
2008
Anogenital warts in children
1997
EFNS guidelines for the diagnosis and management of Alzheimer’s disease
2010
The recent impact of solid-phase synthesis on medicinally relevant benzoannelated nitrogen heterocycles
2002
Parkinson's disease
2009 Standout
Brain perfusion in dementia with Lewy bodies and Alzheimer’s disease: an arterial spin labeling MRI study on prodromal and mild dementia stages
2016
Inverse Relationship Between Cerebrovascular Lesions and Severity of Lewy Body Pathology in Patients With Lewy Body Diseases
2010
Research Evaluation and Prospective Diagnosis of Dementia With Lewy Bodies
2002
Parkinson Disease Neuropathology
2002
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial
2009
A Review of Cognitive Impairments in Dementia with Lewy Bodies Relative to Alzheimer's Disease and Parkinson's Disease with Dementia
2007
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
2000 Standout
Evidence-based Evaluation of Magnetic Resonance Imaging as a Diagnostic Tool in Dementia Workup
2005
Novelty and Anxiolytic Drugs Dissociate Two Components of Hippocampal Theta in Behaving Rats
2013 StandoutNobel
Neurovascular regulation in the normal brain and in Alzheimer's disease
2004 Standout
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
2003
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease
2002
Rivastigmine for Alzheimer's disease
2000
Alzheimer's disease
2006 Standout
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study
2007
Neuropsychological Characteristics of Dementia with Lewy Bodies and Parkinson’s Disease with Dementia: Differentiation, Early Detection, and Implications for “Mild Cognitive Impairment” and Biomarkers
2008
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies
2009
Non-motor features of Parkinson disease
2017 Standout
Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand
2002
HPV detection in children prior to sexual debut
1997
A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease
2009
Quality criteria were proposed for measurement properties of health status questionnaires
2006 Standout
Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes
2014
Effects of fluoxetine on hippocampal rhythmic slow activity and behavioural inhibition
2008
The neuropathology of primary mood disorder
2002
The molecular neurobiology of depression
2008 StandoutNature
Dementia with Lewy bodies and Parkinson's disease with dementia: Are they different?
2005
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
2017 Standout
Large-scale brain networks and psychopathology: a unifying triple network model
2011 Standout
Organic Azides: An Exploding Diversity of a Unique Class of Compounds
2005 Standout
The amyloid state and its association with protein misfolding diseases
2014 Standout
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
2003 Standout
Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial
2006
Efficient Solid‐Phase Synthesis of Highly Functionalized 1,4‐Benzodiazepin‐5‐one Derivatives and Related Compounds by Intramolecular Aza–Wittig Reactions
2005
Management of agitation and aggression associated with Alzheimer disease
2009
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Systematic Review of the Diagnostic Accuracy of 99mTc-HMPAO-SPECT in Dementia
2004
Solid-Phase Intramolecular N-Acyliminium Pictet−Spengler Reactions as Crossroads to Scaffold Diversity
2004 StandoutNobel
Alzheimer Disease as a Vascular Disorder
2002
11C-DTBZ and 18F-FDG PET measures in differentiating dementias.
2005
Hallucinations: The science of idiosyncratic perception.
2008
Idiopathic REM sleep behavior disorder
2005
Altered cortical visual processing in PD with hallucinations
2004
MDS clinical diagnostic criteria for Parkinson's disease
2015 Standout
VBM anticipates the rate of progression of Alzheimer disease
2008
Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI
2004 Standout
Vascular Cognitive Impairment
2014
Non-motor Symptoms of Parkinson's Disease
2007
The Treatment of Alzheimer Disease
2008
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Increased Incidence of Squamous Cell Carcinomas in Mastomys natalensis Papillomavirus E6 Transgenic Mice during Two-Stage Skin Carcinogenesis
2004 StandoutNobel
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Neuroleptic drugs in dementia: benefits and harm
2006
Cortical Activations During Auditory Verbal Hallucinations in Schizophrenia: A Coordinate-Based Meta-Analysis
2010 Standout
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Dementia with Lewy bodies.
2004
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
The MoCA
2010 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Efficacy and Tolerability of Donepezil in Vascular Dementia
2003
α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia
2004
Rivastigmine for Alzheimer's disease
2015
Reduced Vascular Endothelial Growth Factor and Capillary Density in the Occipital Cortex in Dementia with L ewy Bodies
2014
Cholinesterase inhibitors for Alzheimer's disease
2006 Standout
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
2007 Standout
Are Major Dementias Triggered by Poor Blood Flow to the Brain? Theoretical Considerations
2017
Works of Alan Swann being referenced
Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies
2000
Quality of Life for People With Dementia Living in Residential and Nursing Home Care: The Impact of Performance on Activities of Daily Living, Behavioral and Psychological Symptoms, Language Skills, and Psychotropic Drugs
2001
Depression in late life, cognitive decline and white matter pathology in two clinico‐pathologically investigated cases
2001
One Year Follow-Up of Parkinsonism in Dementia with Lewy Bodies
2000
The Natural History of Psychosis and Depression in Dementia With Lewy Bodies and Alzheimer's Disease
2001
Anogenital warts in children
1993
Can psychiatric liaison reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilities
2002
The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease
2001
A 3-Month, Randomized, Placebo-Controlled, Neuroleptic Discontinuation Study in 100 People With Dementia
2004
Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments
2001
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial
2005
Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD
2001
Medial Temporal Lobe Width on CT Scanning in Alzheimer’s Disease: Comparison with Vascular Dementia, Depression and Dementia with Lewy Bodies
2000
Dementia: Management of behavioural and psychological symptoms
2003